Marker Therapeutics MRKR Q4 2025 loss narrows unexpectedly beating estimates by 55 shares tick higher Where is Maiden MHNC stock heading next MHNC Unspecified Quarter Earnings Maiden has no EPS or revenue or analyst estimates STEW SRH Total management outlines longterm portfolio optimization plans in its latest quarterly earnings report What nobody tells you about Valley VLYPN stock 038 20260511 Crane Harbor CHACU Stock Undervalued vs Overpriced Momentum Fading 20260420